Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy

被引:14
作者
Smith, Joshua R. [1 ]
Layrisse, Veronica [1 ,2 ]
Medina-Inojosa, Jose R. [1 ]
Berg, Jessica D. [1 ]
Ommen, Steve R. [1 ]
Olson, Thomas P. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55901 USA
[2] San Juan Bautista Sch Med, Caguas, PR USA
基金
美国国家卫生研究院;
关键词
Functional tolerance; oxygen uptake; hypertrophic cardiomyopathy; septal reduction surgery; LEFT-VENTRICULAR OUTFLOW; OBSTRUCTIVE CARDIOMYOPATHY; SYMPTOMATIC PATIENTS; SURGICAL MYECTOMY; MYOTOMY-MYECTOMY; SURVIVAL; ECHOCARDIOGRAPHY; MANAGEMENT; PROGNOSIS; ABLATION;
D O I
10.1177/2047487319898106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Patients with hypertrophic obstructive cardiomyopathy (HOCM) have impaired exercise capacity. The gold standard therapy for patients with HOCM is septal myectomy surgery; however, changes in maximum oxygen uptake (VO(2)peak) following myectomy are variable, with VO(2)peak decreasing in some patients. Therefore, we evaluated changes in VO(2)peak following surgical myectomy to determine clinical predictors of those exhibiting decreased VO(2)peak post-myectomy. Methods HOCM patients (N = 295) who performed symptom limited cardiopulmonary exercise testing prior to and following surgical myectomy were included for analysis. The VO(2)peak non-responder group (n = 128) was defined as <0% change in VO(2)peak from pre- to post-myectomy. Step-wise regression models using demographics, clinical, and physiologic characteristics were created to determine predictors of hypertrophic cardiomyopathy patients in the VO(2)peak non-responder group. Results Independent predictors of the VO(2)peak non-responder group included higher pre-myectomy VO(2)peak (% predicted), older age, women, history of dyslipidemia, lack of cardiac rehabilitation enrollment, and lower body mass index (all p < 0.03). Forty-three (14.6%) patients reached the primary end-point of all-cause mortality during a median follow up of 11.25 years (interquartile range 6.94 to 16.40). After adjustment for age, sex, beta-blocker use, coronary artery disease history, and body mass index, the VO(2)peak non-responder group had greater risk of death compared with the VO(2)peak responder group (adjusted hazard ratio: 1.77, 95% confidence interval: 1.06-3.34, p = 0.01). Conclusion This large hypertrophic cardiomyopathy cohort demonstrated that demographic (i.e. female sex), lack of cardiac rehabilitation enrollment, and cardiovascular risk factors (i.e. history of dyslipidemia) are predictive of those patients that did not exhibit increases in VO(2)peak following septal myectomy surgery.
引用
收藏
页码:1066 / 1073
页数:8
相关论文
共 31 条
  • [1] Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy
    Coats, Caroline J.
    Rantell, Khadija
    Bartnik, Aleksandra
    Patel, Amour
    Mist, Bryan
    McKenna, William J.
    Elliott, Perry M.
    [J]. CIRCULATION-HEART FAILURE, 2015, 8 (06) : 1022 - 1031
  • [2] Exercise Echocardiography in Asymptomatic HCM
    Desai, Milind Y.
    Bhonsale, Aditya
    Patel, Parag
    Naji, Peyman
    Smedira, Nicholas G.
    Thamilarasan, Masan
    Lytle, Bruce W.
    Lever, Harry M.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2014, 7 (01) : 26 - 36
  • [3] PREDICTORS OF EXERCISE BENEFIT AFTER OPERATIVE RELIEF OF LEFT-VENTRICULAR OUTFLOW OBSTRUCTION BY THE MYOTOMY-MYECTOMY PROCEDURE IN HYPERTROPHIC CARDIOMYOPATHY
    DIODATI, JG
    SCHENKE, WH
    WACLAWIW, MA
    MCINTOSH, CL
    CANNON, RO
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (19) : 1617 - 1622
  • [4] Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy
    Efthimiadis, Georgios K.
    Giannakoulas, Georgios
    Parcharidou, Despina G.
    Pagourelias, Efstathios D.
    Kouidi, Evangelia J.
    Spanos, Georgios
    Kamperidis, Vasileios
    Gavrielides, Stavros
    Karvounis, Haralambos
    Styliadis, Ioannis
    Parcharidis, Georgios E.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (02) : 179 - 184
  • [5] Cardiopulmonary Responses and Prognosis in Hypertrophic Cardiomyopathy A Potential Role for Comprehensive Noninvasive Hemodynamic Assessment
    Finocchiaro, Gherardo
    Haddad, Francois
    Knowles, Joshua W.
    Caleshu, Colleen
    Pavlovic, Aleksandra
    Homburger, Julian
    Shmargad, Yael
    Sinagra, Gianfranco
    Magavern, Emma
    Wong, Myo
    Perez, Marco
    Schnittger, Ingela
    Myers, Jonathan
    Froelicher, Victor
    Ashley, Euan A.
    [J]. JACC-HEART FAILURE, 2015, 3 (05) : 408 - 418
  • [6] Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy - A comparison of clinical, haemodynamic and exercise outcomes
    Firoozi, S
    Elliott, PM
    Sharma, S
    Murday, A
    Brecker, SJ
    Hamid, MS
    Sachdev, B
    Thaman, R
    McKenna, WJ
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1617 - 1624
  • [7] Survival analysis and regression models
    George, Brandon
    Seals, Samantha
    Aban, Inmaculada
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2014, 21 (04) : 686 - 694
  • [8] Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230
  • [9] Women with hypertrophic cardiomyopathy have worse survival
    Geske, Jeffrey B.
    Ong, Kevin C.
    Siontis, Konstantinos C.
    Hebl, Virginia B.
    Ackerman, Michael J.
    Hodge, David O.
    Miller, Virginia M.
    Nishimura, Rick A.
    Oh, Jae K.
    Schaff, Hartzell V.
    Gersh, Bernard J.
    Ommen, Steve R.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (46) : 3434 - U20
  • [10] Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: Results of a structured exercise training program in a cardiac rehabilitation center
    Klempfner, Robert
    Kamerman, Tamir
    Schwammenthal, Ehud
    Nahshon, Amira
    Hay, Ilan
    Goldenberg, Ilan
    Dov, Freimark
    Arad, Michael
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (01) : 13 - 19